Experience

Sintetica

• Switzerland
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Member of Board of Directors, Chief Commercial Officer

  • Jul 2019 - Present

  Mendrisio, Switzerland 2019 onwards: Non-executive board position to provide guidance on strategic business growth and achievement of short & long term goals 2023 onwards: Additional role of CCO to identify & implement key commercial strategies, lead the commercial team of the company and to manage profitable business growth



PharmSky Research

• Australia
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Member of Board of Directors

  • Sep 2023 - Present

  Australia Board member of PharmSky Research, a company focused on "transforming discoveries into market ready products" and an end-to-end Contract Research and Development provider.



CSA Healthcare

• Member of Board of Directors

  • Oct 2017 - Present

  Frankfurt am Main, Germany Mar 2022-Present: Member of Board of Directors Oct 2017-Feb 2022: CEO & Managing Partner CSA Healthcare is a management consultancy in pharma, life-sciences & med-tech space: • Business & Market Entry Strategy: Asia, China, Europe, USA, Oncology, Pain Management, Anaesthesia, Anti-infectives, Critical Care • Portfolio Strategy: Biosimilars, Peptides, Drug Device combinations, Exclusivities, Launches • Acquisitions: Business Due Diligence, Business Planning, Negotiations… Show more Mar 2022-Present: Member of Board of Directors Oct 2017-Feb 2022: CEO & Managing Partner CSA Healthcare is a management consultancy in pharma, life-sciences & med-tech space: • Business & Market Entry Strategy: Asia, China, Europe, USA, Oncology, Pain Management, Anaesthesia, Anti-infectives, Critical Care • Portfolio Strategy: Biosimilars, Peptides, Drug Device combinations, Exclusivities, Launches • Acquisitions: Business Due Diligence, Business Planning, Negotiations, Integration, Interim Mgt • Licensing: In & Out-licensing with focus on differentiated products & NCEs Key interim management roles: (1) Feb-Apr 2020: Archis Pharma Europe, President-Europe (interim management role) (2) Nov 2017-Jun 2018, AMCo (Germany) GmbH, Hamburg (part of Advanz Pharma (previously called Concordia), UK): Vice President-Global Portfolio Management (interim management role) Key Projects: (1) Oct 2018-Present: Ardian, Italy: "Acquisition of a specialty pharma company in Europe with differentiated products" (Jul 2019-present: Sintetica SA, Member of Board of Directors) (2) Aug 2020-Present: "Portfolio selection, go to market strategy, alliances & in-market setup for global rollout of oncology Gx products of an Asian Pharma company" (3) July 2020-Present: "Acquisition of an Asian country business of a top 5 global Pharma & Healthcare company headquartered in Europe" (4) Oct-Nov 2018, top 5 global management consultancy company, USA: "Speciality Injectables: best practices & commercial strategy" Show less



Alliance Pharma Co., Ltd

• Executive Board Member & Deputy Managing Director

  • Mar 2022 - Mar 2023

  Bangkok City, Thailand Executive board position to manage business growth and achievement of short & long term goals of the company



Novitate Pharma Inc

• Founder & Board Member

  • Aug 2020 - Dec 2022

  New Jersey, United States



Fresenius Kabi Deutschland GmbH

• Germany
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Senior Vice President-Portfolio & Strategic Marketing, Mature & Emerging Markets

  • Feb 2015 - Sep 2017

  Oberursel, Hessen, Germany Business targets of pharmaceuticals (anaesthesia, analgesia, anti-infectives, critical care, oncology, biosimilars), business & portfolio development strategies, new therapies, make/buy decisions, licensing, acquisitions, marketing strategies, scientific activities, product launches in Europe, Asia Pacific, Latin America, CIS, Africa and Middle East. Global business development, licensing & strategy for Biosimilars.

• Senior Vice President-Strategic Marketing

  • Aug 2012 - Jan 2015

  Oberursel, Hessen, Germany Strategy, marketing, life cycle management, launches of pharmaceuticals (anaesthesia, analgesia, anti-infectives, critical care, oncology, biosimilars), portfolio management and business development of biosimilars and standard solutions, in USA, Europe, Asia Pacific, Latin America, CIS, Africa and Middle East.

• Senior Vice President-Business Center Oncology

  • Jan 2011 - Jul 2012

  Oberursel, Hessen, Germany Oncology, biosimilars, and compounding business, portfolio-, product development- and marketing strategies, licensing, acquisitions, scientific marketing activities, launches in USA, Europe, Asia Pacific, Latin America and CIS.



Fresenius Kabi

• Germany
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Senior Vice President-Marketing

  • Jan 2009 - Dec 2010

  Hong Kong Senior Vice President – Marketing, Asia Pacific Leading regional team of marketing and sales strategies, regulatory, business development for IV drugs, oncology, clinical nutrition, volume therapy, nephrology and medical devices.



Fresenius Kabi Japan K K

• Member of Board Of Directors

  • Feb 2009 - Apr 2010

  Tokyo, Japan



Dabur Pharma Limited

• Chemical Manufacturing
• 1 - 100 Employee

• Region Head-Asia Pacific, CIS, Latin America, Africa & APIs

  • May 1991 - Dec 2008

  New Delhi, India VP & Region Head-Asia Pacific, CIS, Latin America, Africa & APIs 11/1995 - 12/2008 : Managing business and profitability, market development, sales strategy, marketing initiatives, alliance and distributor management with offices in India, Philippines, Thailand, Malaysia, Vietnam, Russia, Ukraine and Belarus. Strategic business planning for Europe, managing offices in UK and Eastern Europe, business operations of oncology, cosmetics and herbal healthcare products. 05/1991 -… Show more VP & Region Head-Asia Pacific, CIS, Latin America, Africa & APIs 11/1995 - 12/2008 : Managing business and profitability, market development, sales strategy, marketing initiatives, alliance and distributor management with offices in India, Philippines, Thailand, Malaysia, Vietnam, Russia, Ukraine and Belarus. Strategic business planning for Europe, managing offices in UK and Eastern Europe, business operations of oncology, cosmetics and herbal healthcare products. 05/1991 - 10/1995 : Leading team for instrumental analysis, bioequivalence studies, regulatory affairs, GMP / GLP training, validation and stability studies of pharmaceutical, herbal healthcare and cosmetic products Show less



Dabur Pharma (Thailand) Co., Ltd

• Member of Board of Directors

  • Feb 2007 - Aug 2008

  Bangkok, Thailand



Ranbaxy

• India
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Senior Research Scientist

  • Sep 1988 - May 1991

  New Delhi, India Analytical development, bioequivalence studies, regulatory affairs and DMFs for pharmaceutical products



The University of Toledo

• Higher Education
• 700 & Above Employee

• Graduate Teaching Assistant

  • Sep 1986 - Jun 1988

  Toledo, USA Responsible for assisting faculty in teaching and training graduate students